Polymer‐based mRNA delivery strategies for advanced therapies

Wenqian Yang,Lucas Mixich,Eger Boonstra,Horacio Cabral
DOI: https://doi.org/10.1002/adhm.202202688
IF: 10
2023-02-16
Advanced Healthcare Materials
Abstract:Messenger RNA (mRNA) based therapies offer great promise for the treatment of a variety of diseases. In 2020, two FDA approvals of mRNA‐based vaccines have elevated mRNA vaccines to global recognition. However, the therapeutic capabilities of mRNA extend far beyond vaccines against infectious diseases. They hold potential for cancer vaccines, protein replacement therapies, gene editing therapies, and immunotherapies. For realizing such advanced therapies, it is crucial to develop effective carrier systems. Recent advances in material science have led to the development of promising non‐viral mRNA delivery systems. In comparison to other carriers like lipid nanoparticles, polymer‐based delivery systems often receive less attention, despite their unique ability to carefully tune their chemical features to promote mRNA protection, their favorable pharmacokinetics, and their potential for targeting delivery. In this review, we discuss the central features of polymer‐based systems for mRNA delivery highlighting the molecular design criteria, stability, and biodistribution. Finally, we analyze the role of targeting ligands for the future of RNA therapies. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?